Krensavage Asset Management, LLC
Filing Date
Global Rank
#3,686
/ 8,603
▲ 149
· as of Mar 2026
Top Industry
Biotechnology
56.0%
3Y Alpha vs SPY
+2.5%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+87.8%
SPY
+76.5%
Annualised alpha
+2.5%
Max drawdown
−20.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
20 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
19.5%
+1.9 pts
Top 5
64.7%
−2.4 pts
Top 10
86.9%
−6.5 pts
HHI
1,048
Diversified−67
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $255,698,339 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
4 positions
Trimmed
Positions the filer reduced
4 positions
New Positions
Positions the filer opened this quarter
5 positions
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CAH | Cardinal Health Inc | 73,745 | $15,154,597 | |
| No positions match the current search. | ||||
20 positions ·
$255,698,339 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 84,282 | $49,977,540 | 19.55% | |
| ENTA |
Enanta Pharmaceuticals Inc
Healthcare
|
Added | 2,866,138 | $36,199,322 | 14.16% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Held | 167,816 | $31,725,614 | 12.41% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Held | 524,786 | $29,645,161 | 11.59% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
Reduced | 415,693 | $17,829,072 | 6.97% | |
| SNY |
Sanofi
Healthcare
|
Held | 323,946 | $15,607,718 | 6.10% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 280,681 | $14,508,400 | 5.67% | |
| INDV |
Indivior Pharmaceuticals, Inc.
Healthcare
|
NEW | 339,532 | $10,348,935 | 4.05% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 390,879 | $8,188,915 | 3.20% | |
| VNDA |
Vanda Pharmaceuticals Inc.
Healthcare
|
Held | 1,180,388 | $8,156,481 | 3.19% | |
| EMBC |
Embecta Corp.
Healthcare
|
NEW | 735,340 | $6,500,405 | 2.54% | |
| GSK |
GSK plc
Healthcare
|
Held | 96,729 | $5,338,473 | 2.09% | |
| BNTX |
BioNTech SE
Healthcare
|
Reduced | 59,523 | $5,290,404 | 2.07% | |
| ALKS |
Alkermes plc.
Healthcare
|
Held | 107,822 | $3,812,585 | 1.49% | |
| BIIB |
Biogen Inc.
Healthcare
|
Added | 20,000 | $3,666,600 | 1.43% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Held | 4,000 | $3,090,560 | 1.21% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
NEW | 500,000 | $2,995,000 | 1.17% | |
| INMD |
InMode Ltd.
Healthcare
|
NEW | 120,942 | $1,654,486 | 0.65% | |
| EOLS |
Evolus, Inc.
Healthcare
|
Added | 157,985 | $649,318 | 0.25% | |
| ABT |
Abbott Laboratories
Healthcare
|
NEW | 5,000 | $513,350 | 0.20% |